Topic

Elias Jabbour

1 recent story · updated continuously

Benzinga

Ascentage Pharma Reports Promising Phase Ib Results for Olverembatinib at ASCO 2026

healthJust now
Ascentage Pharma Reports Promising Phase Ib Results for Olverembatinib at ASCO 2026